Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
This kit is used for in vitro qualitative detection of EGFR, KRAS, BRAF, PIK3CA gene mutations and ALK, ROS1 gene fusions in 10% neutral formalin-fixed paraffin-embedded tissue (FFPE) samples of patients with non-small cell lung cancer, including EGFR gene L858R, T790M, G719A, S768I, EGFR gene exon 19 deletion, KRAS gene G12V/C/D/R/A/S, G13D mutations, BRAF gene V600E mutation, PIK3CA gene E545K, H1047R mutations and ALK, ROS1 gene fusions. Among them, EGFR exon 19 deletion (19del) and L858R point mutation are used for companion diagnosis of gefitinib tablets and icotinib hydrochloride tablets, EGFR T790M point mutation is used for companion diagnosis of osimertinib mesylate tablets, ALK gene fusion (rearrangement) and ROS1 gene fusion (rearrangement) are used for companion diagnosis of crizotinib capsules.
This report is a detailed and comprehensive analysis for global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jinqirui Biotechnology, Hangzhou Lianchuan Gene, Xiamen Feishuo Biotechnology, Novogene, Burning Rock, Shihe Medical, Qiuzhen Medical, Yuanma Gene, BGI, AmoyDx, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Sequencing Method
Fluorescence PCR Method
Other
Market segment by Application
Clinical
Scientific Research
Major players covered
Jinqirui Biotechnology
Hangzhou Lianchuan Gene
Xiamen Feishuo Biotechnology
Novogene
Burning Rock
Shihe Medical
Qiuzhen Medical
Yuanma Gene
BGI
AmoyDx
HLB PanaGene
TRUPCR
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit, with price, sales quantity, revenue, and global market share of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit from 2020 to 2025.
Chapter 3, the Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit.
Chapter 14 and 15, to describe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit sales channel, distributors, customers, research findings and conclusion.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
This kit is used for in vitro qualitative detection of EGFR, KRAS, BRAF, PIK3CA gene mutations and ALK, ROS1 gene fusions in 10% neutral formalin-fixed paraffin-embedded tissue (FFPE) samples of patients with non-small cell lung cancer, including EGFR gene L858R, T790M, G719A, S768I, EGFR gene exon 19 deletion, KRAS gene G12V/C/D/R/A/S, G13D mutations, BRAF gene V600E mutation, PIK3CA gene E545K, H1047R mutations and ALK, ROS1 gene fusions. Among them, EGFR exon 19 deletion (19del) and L858R point mutation are used for companion diagnosis of gefitinib tablets and icotinib hydrochloride tablets, EGFR T790M point mutation is used for companion diagnosis of osimertinib mesylate tablets, ALK gene fusion (rearrangement) and ROS1 gene fusion (rearrangement) are used for companion diagnosis of crizotinib capsules.
This report is a detailed and comprehensive analysis for global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jinqirui Biotechnology, Hangzhou Lianchuan Gene, Xiamen Feishuo Biotechnology, Novogene, Burning Rock, Shihe Medical, Qiuzhen Medical, Yuanma Gene, BGI, AmoyDx, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Sequencing Method
Fluorescence PCR Method
Other
Market segment by Application
Clinical
Scientific Research
Major players covered
Jinqirui Biotechnology
Hangzhou Lianchuan Gene
Xiamen Feishuo Biotechnology
Novogene
Burning Rock
Shihe Medical
Qiuzhen Medical
Yuanma Gene
BGI
AmoyDx
HLB PanaGene
TRUPCR
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit, with price, sales quantity, revenue, and global market share of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit from 2020 to 2025.
Chapter 3, the Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit.
Chapter 14 and 15, to describe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit sales channel, distributors, customers, research findings and conclusion.
Table of Contents
111 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
